Femasys Inc (FEMY): Operating Income

Annual figures by period end, from SEC filings.

-$17.59M
Year ended 2025-12-31
-$17.57M
Trailing 12 months to 2026-06-30
2020-12-31: -$6.93M2021-12-31: -$8.34M2022-12-31: -$11.60M2023-12-31: -$14.51M2024-12-31: -$17.79M2025-12-31: -$17.59M-$17.59M
2020-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31-$17.59Mn/m2026-03-31, From 2025-01-01
2024-12-31-$17.79Mn/m2026-03-31, From 2024-01-01
2023-12-31-$14.51Mn/m2025-03-27, From 2023-01-01
2022-12-31-$11.60Mn/m2024-03-28, From 2022-01-01
2021-12-31-$8.34Mn/m2023-07-24, From 2021-01-01
2020-12-31-$6.93Mn/a2022-03-24, From 2020-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Femasys Inc (FEMY)2025-12-31-$17.59Mn/m
QHSLab, Inc. (USAQ)2025-12-31$131.2K-36.2%
Vycor Medical Inc (VYCO)2025-12-31$33.9Kn/m
OSR Health, Inc. (OSRH)2025-12-31-$18.34Mn/m
EBR Systems, Inc. (NONE.)2025-12-31-$46.09Mn/m
Nuo Therapeutics, Inc. (AURX)2025-12-31-$2.52Mn/m
IceCure Medical Ltd. (ICCM)2025-12-31-$15.09Mn/m
Tenon Medical, Inc. (TNON)2025-12-31-$12.79Mn/m
Intelligent Bio Solutions Inc. (INBS)2026-06-30-$12.61Mn/m

Compare FEMY, USAQ, VYCO, OSRH side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗